Our Formulations business boasts a broad portfolio of innovative and established medicines. Leveraging our people, market intelligence, global and local presence, R&D capabilities and strong ties with manufacturers, we produce and sell finished formulations to institutional and private clients in both emerging and regulated countries.
Our products can be categorised into four categories: Generics, Alternative Medicines, Biologicals and Animal Nutrition. However, our expertise lies in our ability to craft even the most complex of formulations.
Our products are approved in individual countries for specific uses and the information provided is governed by local regulations. Availability, Name and Indicated Use may change from country to country. Please contact your local SRS office to learn more about products available in your country.
Not all products may be listed and this list may be updated at any time. Always ask a healthcare professional for advice before taking medicines.
|Active Ingredients||Dosage form||Target market||Category||Therapeutic Category|
|1||Mometasone Fuorate Nasal Spray
|2||Budesonide 200 µg
|3||Iohexol 240 mg I/ ml
Iohexol 300 mg I/ ml
Iohexol 350 mg I/ ml
|Developed for Emerging Markets||Generic||Contrast Media|
|4||Isoxsuprine 5 mg/ ml
||Developed||Generic||Tocolytic and vasodialator|
|5||Bacillus coagulans 1 billion CFU
Bacillus coagulans 2 billion CFU
|Developed for Emerging Markets||Probiotic||Digestive Health|
|6||Lactobacillus reuteri 200 mg
||Soft Gelatin Capsule
||Developed||Probiotic||H. pylori infection|
|7||Common Ivy (Hedera Helix) 7 mg/ ml
Common Ivy (Hedera Helix) 65 mg
|Developed for Emerging Markets (Effervescent Tablet Under Development)||Alternative Medicine||Anti-tussive & Expectorant|
|8||Comfrey Extract 35%
||Under Development||Alternative Medicine||Anti-inflammatory|